Search hospitals > Alberta > CALGARY
Tom Baker Cancer Centre
Claim this profileCALGARY, Alberta T2N 4N2
Global Leader in Breast Cancer
Global Leader in Cancer
Conducts research for Prostate Cancer
Conducts research for Multiple Myeloma
Conducts research for Lung Cancer
551 reported clinical trials
29 medical researchers
Summary
Tom Baker Cancer Centre is a medical facility located in CALGARY, Alberta. This center is recognized for care of Breast Cancer, Cancer, Prostate Cancer, Multiple Myeloma, Lung Cancer and other specialties. Tom Baker Cancer Centre is involved with conducting 551 clinical trials across 345 conditions. There are 29 research doctors associated with this hospital, such as Prafull Ghatage, MD, Marc Webster, Sonia Cerquozzi, MD, and Patricia Tang.Area of expertise
1Breast Cancer
Global LeaderStage IV
HER2 negative
Stage III
2Cancer
Global LeaderStage IV
Stage III
t(11;14) positive
Top PIs
Prafull Ghatage, MDTom Baker Cancer Centre5 years of reported clinical research
Studies Ovarian Cancer
Studies Cancer
9 reported clinical trials
17 drugs studied
Marc WebsterTom Baker Cancer Center5 years of reported clinical research
Studies Breast Cancer
Studies Nasopharyngeal Carcinoma
8 reported clinical trials
22 drugs studied
Sonia Cerquozzi, MDTom Baker Cancer Centre4 years of reported clinical research
Studies Myelofibrosis
Studies Primary Myelofibrosis
3 reported clinical trials
4 drugs studied
Patricia TangTom Baker Cancer Centre5 years of reported clinical research
Studies Colon Cancer
Studies Pancreatic Cancer
3 reported clinical trials
11 drugs studied
Clinical Trials running at Tom Baker Cancer Centre
Multiple Myeloma
Breast Cancer
Cancer
Pancreatic Cancer
Bladder Cancer
Glioblastoma
Brain Tumor
Acute Lymphoblastic Leukemia
Myelodysplastic Syndrome
Anemia
Elranatamab Access
for Multiple Myeloma
This is a post-trial access (PTA) open-label, single-arm study in Multiple Myeloma participants who continue to derive clinical benefit from elranatamab monotherapy in the Pfizer-sponsored elranatamab Parent Studies.
Recruiting3 awards Phase 42 criteria
Talquetamab Combinations
for Multiple Myeloma
This trial is testing two new drug combinations to treat multiple myeloma. The combinations include talquetamab with either pomalidomide or teclistamab. These drugs help the immune system better identify and destroy cancer cells. The goal is to see if these new combinations work better than existing treatments.
Recruiting2 awards Phase 35 criteria
Elranatamab Combinations
for Multiple Myeloma
The purpose of this clinical trial is to (1) learn whether the BCMA-CD3 bispecific antibody elranatamab can provide more benefit to people with multiple myeloma compared to a combination therapy including daratumumab, pomalidomide, and dexamethasone, and (2) learn about the safety and activity of elranatamab in combination with the anti-CD38 monoclonal antibody daratumumab. People with multiple myeloma who have received previous treatment including lenalidomide will be enrolled in the study. Part 1 of the study will assess the safety and activity of different doses of elranatamab in combination with daratumumab. People participating in Part 2 of the study will be randomly assigned to receive either elranatamab alone, elranatamab plus daratumumab, or daratumumab, pomalidomide, and dexamethasone. Part 2 will evaluate the safety and activity of (1) elranatamab alone compared to daratumumab, pomalidomide, and dexamethasone, and (2) elranatamab plus daratumumab. Part 3 will assess the effect of increased measures to protect against infection in people treated with either elranatamab alone or together with daratumumab. All people participating in the study will receive study treatment until their disease progresses, they experience unacceptable side effects, or they choose to no longer participate in the study.
Recruiting2 awards Phase 36 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Tom Baker Cancer Centre?
Tom Baker Cancer Centre is a medical facility located in CALGARY, Alberta. This center is recognized for care of Breast Cancer, Cancer, Prostate Cancer, Multiple Myeloma, Lung Cancer and other specialties. Tom Baker Cancer Centre is involved with conducting 551 clinical trials across 345 conditions. There are 29 research doctors associated with this hospital, such as Prafull Ghatage, MD, Marc Webster, Sonia Cerquozzi, MD, and Patricia Tang.
Where is Tom Baker Cancer Centre located?
**Tom Baker Cancer Centre**
- **Location:** 1331 29 Street NW, Calgary, Alberta T2N 4N2, within the Foothills Medical Centre.
- **Services:** A tertiary care facility serving Southern Alberta, the Tom Baker Cancer Centre offers comprehensive cancer care including prevention, research, treatment programs, and supportive care for both inpatients and outpatients.
Who should I call to ask about financial aid or insurance network?
**Tom Baker Cancer Centre Contact Information:**
- **Financial Assistance:** Patients seeking financial aid can reach the Patient Resource Office at 403-355-3207. This program assists eligible patients by covering certain direct care costs, including travel, accommodations for appointments, and medications not covered by insurance.
- **Insurance Inquiries:** For questions related to insurance, please contact the switchboard at 403-355-3207 to be connected to the appropriate department.
What insurance does Tom Baker Cancer Centre accept?
The Tom Baker Cancer Centre collaborates with a wide range of insurance providers, including Blue Cross, commercial insurance plans, Medicare, Medicare Part C, Medicaid, U.S. Department of Veterans Affairs, and TRICARE plans. Most cancer treatment drugs are covered, though there may be exceptions. Additionally, the center offers an Outpatient Cancer Drug Benefit Program for those covered by the Alberta Health Care Insurance Plan and registered in the Cancer Registry.
What awards or recognition has Tom Baker Cancer Centre received?
The Tom Baker Cancer Centre, located in Calgary, Alberta, serves as a tertiary care facility for Southern Alberta and is one of two tertiary cancer centers in the province. It specializes in prevention, research, and treatment programs, offering advanced medical and supportive care for both inpatients and outpatients, in collaboration with the Charbonneau Cancer Institute. The center has also been bolstered by a $25 million donation from the Riddell family, aimed at combating treatment-resistant cancers, leading to the establishment of the Riddell Centre for Cancer Immunotherapy.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.